Multiplicom
Universiteit Antwerpen

Multiplicom

Biotech
Biotech
Biotech
Biotech

Acquired by Agilent Technologies.

Multiplicom was created in 2011 as a spin-off of the University of Antwerp and VIB. Multiplicom develops, manufactures and commercializes leading-edge and easy-to-use genetic test kits based on the latest molecular diagnostic technologies. Multiplicom produces molecular diagnostic kits that enable clinical laboratories to perform affordable testing for personalized medicine.

Acquired by Agilent Technologies.

No items found.

This company is aligned with the following SDGs

No items found.
Flindr Therapeutics
Qbic III
Biotech
Biotech
Biotech
Biotech

Flindr Therapeutics

Flindr aims to restore a patient’s impaired immune response to cancer

Universiteit Gent
Swave
Qbic III
Deeptech
Deeptech
Deeptech
Deeptech

Swave

Swave develops holographic eXtended reality technology to make virtual reality practically indistinguishable from the real world.

imec
VUB
Trince
Qbic II
Biotech
Biotech
Biotech
Biotech

Trince

Trince developed a new transfection technology based on a combination of laser light and photothermal nanoparticles.

Universiteit Gent